Pharma-Bio Serv, Inc. Quarterly Liabilities and Equity in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Pharma-Bio Serv, Inc. quarterly Liabilities and Equity history and growth rate from Q3 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Liabilities and Equity for the quarter ending July 31, 2024 was $16.3M, a 19.6% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $16.3M -$3.98M -19.6% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $16.9M -$2.69M -13.7% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $19.2M -$3.67M -16% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $19.9M -$749K -3.63% Oct 31, 2023 10-Q 2024-09-16
Q2 2023 $20.3M -$32.2K -0.16% Jul 31, 2023 10-Q 2023-09-14
Q1 2023 $19.6M -$543K -2.69% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $22.9M +$826K +3.74% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 $20.7M -$3.27M -13.7% Oct 31, 2022 10-K 2024-01-29
Q2 2022 $20.3M -$8.27M -28.9% Jul 31, 2022 10-Q 2022-09-14
Q1 2022 $20.2M -$7.74M -27.7% Apr 30, 2022 10-Q 2022-06-14
Q4 2021 $22.1M -$8.12M -26.9% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 $23.9M -$6M -20% Oct 31, 2021 10-K 2023-01-30
Q2 2021 $28.6M -$1.51M -5.01% Jul 31, 2021 10-Q 2021-09-14
Q1 2021 $27.9M -$737K -2.57% Apr 30, 2021 10-Q 2021-06-14
Q4 2020 $30.2M +$4.04M +15.4% Jan 31, 2021 10-Q 2021-03-17
Q3 2020 $29.9M +$3.29M +12.3% Oct 31, 2020 10-K 2022-02-11
Q2 2020 $30.1M +$3.85M +14.7% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $28.6M +$2.98M +11.6% Apr 30, 2020 10-Q 2020-06-15
Q4 2019 $26.2M +$877K +3.47% Jan 31, 2020 10-Q 2020-03-16
Q3 2019 $26.6M +$1.25M +4.94% Oct 31, 2019 10-K 2021-02-01
Q2 2019 $26.3M +$2.94M +12.6% Jul 31, 2019 10-Q 2019-09-16
Q1 2019 $25.7M +$3.14M +14% Apr 30, 2019 10-Q 2019-06-14
Q4 2018 $25.3M +$2.87M +12.8% Jan 31, 2019 10-Q 2019-03-18
Q3 2018 $25.4M +$3.03M +13.5% Oct 31, 2018 10-K 2020-01-29
Q2 2018 $23.3M +$797K +3.54% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 $22.5M -$52.4K -0.23% Apr 30, 2018 10-Q 2018-06-14
Q4 2017 $22.4M -$647K -2.81% Jan 31, 2018 10-Q 2018-03-19
Q3 2017 $22.4M -$1.65M -6.87% Oct 31, 2017 10-K 2019-01-29
Q2 2017 $22.5M -$1.51M -6.28% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 $22.6M -$1.65M -6.81% Apr 30, 2017 10-Q 2017-06-14
Q4 2016 $23.1M -$780K -3.27% Jan 31, 2017 10-Q 2017-03-17
Q3 2016 $24M -$141K -0.59% Oct 31, 2016 10-K 2018-01-29
Q2 2016 $24M +$706K +3.03% Jul 31, 2016 10-Q 2016-09-14
Q1 2016 $24.2M +$1.12M +4.85% Apr 30, 2016 10-Q 2016-06-14
Q4 2015 $23.8M +$889K +3.87% Jan 31, 2016 10-Q 2016-03-16
Q3 2015 $24.1M +$928K +4% Oct 31, 2015 10-K 2017-01-31
Q2 2015 $23.3M +$1.29M +5.83% Jul 31, 2015 10-Q 2015-09-14
Q1 2015 $23.1M +$1.49M +6.88% Apr 30, 2015 10-Q 2015-06-15
Q4 2014 $22.9M +$1.87M +8.87% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 $23.2M +$1.93M +9.07% Oct 31, 2014 10-K 2016-01-29
Q2 2014 $22M +$2.92M +15.3% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 $21.6M +$3.57M +19.8% Apr 30, 2014 10-Q 2014-06-16
Q4 2013 $21.1M +$4.68M +28.5% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $21.3M +$5.55M +35.3% Oct 31, 2013 10-K 2015-01-29
Q2 2013 $19.1M +$5.19M +37.3% Jul 31, 2013 10-Q 2013-09-16
Q1 2013 $18M +$5.52M +44.1% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 $16.4M +$4.93M +43% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 $15.7M +$4.88M +45% Oct 31, 2012 10-K 2014-01-29
Q2 2012 $13.9M +$4.44M +46.9% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 $12.5M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 $11.5M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 $10.9M +$4.29M +65.5% Oct 31, 2011 10-K 2013-01-29
Q2 2011 $9.48M Jul 31, 2011 10-Q 2011-09-14
Q3 2010 $6.56M Oct 31, 2010 10-K/A 2012-01-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.